Survey Examining the Frequency and Severity of Acid Related Symptoms While Taking Nexium
NCT01130935 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 491
Last updated 2011-02-24
Summary
This study will assess the effectiveness of Nexium at alleviating upper GI symptoms in subjects and evaluate with which treatment regimen and on which indications acid suppression with isomeric proton pump inhibitor is used in routine clinical practice in Albania.
Conditions
- Gastric Acid Suppression
- Proton Pump Inhibitors
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Karin Otter, MD, PhD · Medical Director BBC
-
Senka Riza · Medical and Regulatory Manager
-
Skerdi Prifti, Asc.Proff. · University Hospital Center "Mother Teresa"
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2010-11-30
- Completion
- 2010-11-30
Countries
- Albania
Study Locations
More Related Trials
-
Nexium RESPONSE Trial
NCT00318968 ·Status: COMPLETED ·Phase: PHASE4
-
PPI Test in GP Patients
NCT00318084 ·Status: COMPLETED ·Phase: PHASE4
-
Adult Asthmatics and Acid Reflux
NCT00628953 ·Status: COMPLETED ·Phase: PHASE2
-
Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation
NCT01562600 ·Status: COMPLETED
-
S-CEI of Nexium in Paediatric Patients
NCT03562026 ·Status: COMPLETED
-
Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome
NCT00079833 ·Status: COMPLETED ·Phase: PHASE3
-
Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.
NCT05267613 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects
NCT03211143 ·Status: COMPLETED ·Phase: PHASE1
-
Nexium Dyspepsia/AST
NCT00251992 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma
NCT00317044 ·Status: COMPLETED ·Phase: PHASE2
-
The Utility of Nexium in Chronic Cough and Reflux Disease
NCT00287339 ·Status: COMPLETED ·Phase: PHASE4
-
Acid-Associated Heartburn Symptoms and Dose of Esomeprazole
NCT00206024 ·Status: COMPLETED ·Phase: PHASE4
-
Nexium Capsules Clinical Experience Investigation
NCT01434485 ·Status: COMPLETED
-
Esomeprazole (NEXIUM) vs. Surgery
NCT00251927 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Gastric Ulcers
NCT00629512 ·Status: COMPLETED ·Phase: PHASE3
-
Nexium Dyspepsia/AST
NCT00251914 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)
NCT00242736 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Daily Use Proton Pump Inhibitors for One Month on Kidney Function
NCT03910647 ·Status: UNKNOWN ·Phase: PHASE2
-
Nexium Capsules LDA Specific Clinical Experience Investigation
NCT01729182 ·Status: COMPLETED
-
NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis
NCT00206180 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)
NCT00734097 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population
NCT00259051 ·Status: COMPLETED ·Phase: PHASE3
-
Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients
NCT00444275 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Esomeprazole in Patients With Frequent Heartburn
NCT01370538 ·Status: COMPLETED ·Phase: PHASE3
-
ASTERIX: Low Dose ASA and Nexium
NCT00251966 ·Status: COMPLETED ·Phase: PHASE3